| Financial Year |
March 31 2022 |
| Monetary Funds |
13,162,343.21 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
141,660,315.87 |
| Advances to Suppliers |
76,220,987.90 |
| Other Receivables |
224,153,710.58 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,735,503.58 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
12,812,429.85 |
| Other Current Assets |
731,718,252.15 |
| Total Current Assets |
1,203,463,543.14 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
961,610.11 |
| Long-term Equity Investment |
334,330,099.07 |
| Investment Properties |
59,328,126.37 |
| Fixed Assetes |
2,732,087.14 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
504,194.41 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
352,008.31 |
| Sub-Total of Non-Current Assets |
448,208,125.41 |
| Total Assets |
1,651,671,668.55 |
| Short-Term Loans |
1,542,582,685.60 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
252,636,706.91 |
| Accounts Received In Advance |
175,000.00 |
| Employee Compensation Payable |
10,591,598.60 |
| Taxes Payable |
304,192,540.14 |
| Interest Payable |
778,446,076.24 |
| Dividend Payable |
-- |
| Other payables |
1,164,253,933.21 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
82,176,482.28 |
| Other Current Liabilities |
2,555,232,887.03 |
| Sub-Total of Current Liabilities |
6,338,402,138.32 |
| Long-term Loans |
500,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
3,842,336.30 |
| Special Payable |
-- |
| Estimatied Liabilities |
658,973.46 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
504,501,309.76 |
| Total Liabilities |
6,842,903,448.08 |
| Paid-In Capital(Or Share Stock) |
1,122,447,500.00 |
| Capital Surplus |
4,038,883,027.35 |
| Surplus Reserve |
103,502,698.19 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-10,487,364,388.70 |
| Minority Stockholder's Interest |
-105,988,683.61 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-5,085,243,095.92 |
| Owner's Equity（Stockholder's Equity） |
-5,191,231,779.53 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,651,671,668.55 |
